Clovis Oncology, Inc. reports

Company location: Boulder, CO
Fiscal year end: 31 December

Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 76-100 of 951 matching filings.

Per page

25

Current page

4

DEF 14A File 001-35347

DEF 14A

Filing date: 27 Apr 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-35347

PRE 14A

Filing date: 15 Apr 2022
Reporting date: 09 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86488

SC 13G/A filing

Filing date: 11 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Apr 2022
Reporting date: 01 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86488

SC 13G/A filing

Filing date: 11 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-35347

10-K

Filing date: 24 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35347

8-K

Filing date: 23 Feb 2022
Reporting date: 23 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-86488

SC 13G/A filing

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86488

CLOVIS ONCOLOGY, INC.

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86488

SC 13G/A filing

Filing date: 11 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86488

SCHEDULE 13G/A

Filing date: 09 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-86488

SC 13G filing

Filing date: 08 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35347

8-K

Filing date: 10 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jan 2022
Reporting date: 01 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .